These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2462897)

  • 1. Interferon therapy--molecular mechanisms and clinical applications. Proceedings of a satellite symposium held at the 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Spain, 1st-4th November 1987.
    Br J Clin Pract Suppl; 1988 Mar; 62():1-26. PubMed ID: 2462897
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide in the treatment of pediatric malignancies. 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, November 1987. Proceedings.
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S1-51. PubMed ID: 2758565
    [No Abstract]   [Full Text] [Related]  

  • 3. Paraplatin (carboplatin): new advances in cancer therapy. Update on clinical experiences. Proceedings of a satellite symposium. Madrid, Spain, 2 November 1987.
    Cancer Treat Rev; 1988 Jun; 15 Suppl B():1-44. PubMed ID: 3042129
    [No Abstract]   [Full Text] [Related]  

  • 4. Papers presented at ECCO-4. 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Nover 1-4, 1987.
    Acta Oncol; 1988; 27(5):465-589. PubMed ID: 3203004
    [No Abstract]   [Full Text] [Related]  

  • 5. Ifosfamide in gynecological tumors. Satellite symposium of 5th European Conference on Clinical Oncology and Cancer Nursing. London, September 3-7, 1989. Proceedings.
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S1-102. PubMed ID: 2347044
    [No Abstract]   [Full Text] [Related]  

  • 6. The biological therapy of cancer: a clinical symposium. Dana Point, California, April 8th and 9th, 1988. Proceedings.
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):1-57. PubMed ID: 2461591
    [No Abstract]   [Full Text] [Related]  

  • 7. Paraplatin (carboplatin). Current status and future prospects. Proceedings of a satellite symposium held at Stockholm, Sweden, 19th June 1985, during the 3rd European Conference on Clinical Oncology.
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():1-152. PubMed ID: 3910214
    [No Abstract]   [Full Text] [Related]  

  • 8. Current and future aspects on the clinical use of Ara-C in leukemia. Proceedings from a symposium held at the 3rd European Conference on Clinical Oncology and Cancer Nursing, June 19, 1985, in Stockholm.
    Scand J Haematol Suppl; 1986; 44():1-74. PubMed ID: 3457436
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of interferon therapy in oncology.
    Roth MS; Foon KA
    Prog Hematol; 1987; 15():19-38. PubMed ID: 2459731
    [No Abstract]   [Full Text] [Related]  

  • 10. International Symposium on Interferon-Alpha Therapy in Malignant Diseases. Athens, November 1-4, 1990. Proceedings.
    Br J Haematol; 1991 Oct; 79 Suppl 1():1-104. PubMed ID: 1718387
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferons in oncology.
    Woll PJ; Pettengell R
    Br J Clin Pract; 1997 Mar; 51(2):111-5. PubMed ID: 9158255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent experience with ifosfamide/mesna in solid tumors. International satellite symposium to the 3rd European Conference on Clinical Oncology. Stockholm, June 1985. Proceedings.
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S1-58. PubMed ID: 3102087
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon alfa-2a in cancer therapy. Proceedings of an official satellite symposium to the 14 International UICC Cancer Congress. Budapest, Hungary, 22 August 1986.
    Int J Cancer Suppl; 1987; 1():1-45. PubMed ID: 3476472
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferons in the treatment of advanced breast cancer.
    Repetto L; Venturino A; Simoni C; Rosso M; Melioli G; Rosso R
    J Biol Regul Homeost Agents; 1993; 7(4):109-14. PubMed ID: 7517612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy of cancer with interferon: lessons from tumor models and perspectives for clinical applications.
    Ferrantini M; Belardelli F
    Semin Cancer Biol; 2000 Apr; 10(2):145-57. PubMed ID: 10936064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperthermia in oncology: the state and prospects. Analytical review of Proceedings of the 4th International Symposium on the Hyperthermic Oncology, Aarhus, Denmark, 2-6 July 1984].
    Kozin SV; Iarmonenko SP
    Med Radiol (Mosk); 1986 Jun; 31(6):63-72. PubMed ID: 3724386
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of interferon in experimental and clinical oncology based on data from foreign scientific research centers].
    Sil'chenko NN; Stanzhevskaia TI; Fedoskina VV
    Vopr Onkol; 1985; 31(1):3-8. PubMed ID: 2579507
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in cancer chemotherapy. Proceedings of a symposium of the 5th European Conference on Clinical Oncology. September 3, 1989, London.
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):1-74. PubMed ID: 2305268
    [No Abstract]   [Full Text] [Related]  

  • 20. Current clinical status of interferon and management of cancer in man.
    Horoszewicz JS; Mirand EA
    Prog Clin Biol Res; 1983; 132E():315-25. PubMed ID: 6196789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.